Birmingham, AL, United States of America

Murray A Stackhouse


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Helena, AL (US) (1999 - 2002)
  • Birmingham, AL (US) (2003)

Company Filing History:


Years Active: 1999-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Murray A. Stackhouse

Introduction

Murray A. Stackhouse is a prominent inventor based in Birmingham, AL (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 5 patents, Stackhouse has focused on enhancing the effectiveness of cancer therapies.

Latest Patents

One of his latest patents is titled "Molecular chemotherapy enhancement of radiotherapy." This invention provides a new approach for cancer treatment by utilizing gene therapy combined with radiation therapy to enhance cytotoxicity in malignant cells. Specifically, it demonstrates that molecular chemotherapy with the cytosine deaminase gene and 5-fluorocytosine is an effective radiosensitizing strategy. This method may lead to substantial improvement in tumor control, with less normal tissue toxicity than conventional systemic administration of 5-fluorouracil, ultimately translating into improved cure rates and better survival. Additionally, the invention includes a noninvasive method for continuous in vivo monitoring of 5-fluorouracil production via magnetic resonance spectroscopy.

Another significant patent by Stackhouse is "Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies." This invention provides a method of enhancing the chemosensitivity and radiosensitivity of neoplastic cells expressing an oncoprotein that stimulates cell proliferation. The method involves introducing a nucleic acid molecule encoding an antibody homologue, which is expressed intracellularly and binds to the oncoprotein in the endoplasmic reticulum of the cell. This approach aims to enhance the inhibition of proliferation of neoplastic cells when combined with anti-neoplastic agents.

Career Highlights

Murray A. Stackhouse is associated with the UAB Research Foundation, where he continues to work on groundbreaking research in cancer therapies. His innovative work has garnered attention in the scientific community and has the potential to significantly impact cancer treatment protocols.

Collaborations

Throughout his career, Stackhouse has collaborated with notable colleagues, including Donald J. Buchsbaum and David T. Curiel. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Murray A. Stackhouse is a distinguished inventor whose work in cancer treatment through innovative methodologies has the potential to change the landscape of oncology. His patents reflect a commitment to improving patient outcomes and advancing

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…